Ro 08-2750

• CAT Number: I009066
• CAS Number: 37854-59-4
• Molecular Formula: C13H10N4O3
• Molecular Weight: 270.25
• Purity: ≥95%
• Synonyms: Ro 08-2750; Ro08-2750; Ro-08-2750; Ro 082750; Ro -082750; Ro082750.;2,3,4,10-Tetrahydro-7,10-dimethyl-2,4-dioxobenzo[g]pteridine-8-carboxaldehyde
• Target: Apoptosis
• Solubility: Soluble in DMSO, not in water
• Storage: Store at -20 °C
• IUPAC Name: 7,10-dimethyl-2,4-dioxobenzo[g]pteridine-8-carbaldehyde
• InChI: InChI=1S/C13H10N4O3/c1-6-3-8-9(4-7(6)5-18)17(2)11-10(14-8)12(19)16-13(20)15-11/h3-5H,1-2H3,(H,16,19,20)
• InChIKey: JDEMVNYMYPJJIM-UHFFFAOYSA-N
• SMILES: CC1=CC2=C(C=C1C=O)N(C3=NC(=O)NC(=O)C3=N2)C

RO 08-2750(Cat No.:I009066 ) is a selective serotonin-norepinephrine reuptake inhibitor (SSNRI) used for treating major depressive disorder (MDD) and generalized anxiety disorder (GAD). It increases serotonin and norepinephrine levels, improving mood and anxiety symptoms. It has shown efficacy and safety in clinical trials, though side effects may include nausea, dizziness, and sleep disturbances. Additionally, RO 08-2750 is a potent nerve growth factor (NGF) inhibitor, which may help address intervertebral disc (IVD) degeneration and reduce pain by mitigating tissue breakdown.